Rituximab Improves Systemic Sclerosis Skin, Lung Symptoms Rituximab Improves Systemic Sclerosis Skin, Lung Symptoms

Patients who took rituximab in the DESIRES trial had better skin scores and lung function at 6 months than did patients who received placebo.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news